Cumberland Pharmaceuticals Inc (CPIX.OQ)
* Stonepine Capital Management Llc reports 6.8 percent passive stake in Cumberland Pharmaceuticals Inc as of May 9 - SEC filing Source text for Eikon: (http://bit.ly/2qA4bqN) Further company coverage:
* Cumberland pharmaceuticals reports revenue growth of 25% in first quarter 2017
BRIEF-Cumberland Pharmaceuticals entered into a co-promotion partnership with Poly Pharmaceuticals for Kristalose within U.S.
* Cumberland Pharmaceuticals Inc - Entered into a co-promotion partnership with Poly Pharmaceuticals Inc for Kristalose within United States
BRIEF-Cumberland Pharmaceuticals says caldolor demonstrates significant post surgical pain reduction and decrease in opioid use
* Cumberland Pharmaceuticals Inc says Caldolor demonstrates significant post surgical pain reduction and decrease in opioid use Source text for Eikon: Further company coverage:
A federal appeals court on Thursday dealt another blow to Mylan Inc’s plans to offer a generic version of an improved antidote for acetaminophen poisoning, ruling that Cumberland Pharmaceutical’s patent on the product was valid.
* Cumberland pharmaceuticals and Clinigen enter exclusive U.S. commercialization agreement for Totect